Table 2

Summary of incubation conditions and analytical methods for in vitro metabolism assays

Index ReactionReaction TimeMicrosomal Protein ConcentrationInternal StandardAnalytical Method
LiverLymphoblastColumn2-aMobile PhaseFlow RateDetection System
min μg/ml ml/min
Ethoxyresorufin O-deethylation (CYP1A2)562.5160PhenacetinHPLC; A65:35 25 mM KH2PO4 (pH 7):CH3OH0.8Resorufin: fluorescence (excitation 530 nm, emission 580 nm); phenacetin: UV 230 nm
Methoxyresorufin O-deethylation (CYP1A2)462.580PhenacetinHPLC; A65:35 25 mM KH2PO4 (pH 7):CH3OH0.8Resorufin: fluorescence (excitation 530 nm, emission 580 nm); phenacetin: UV 230 nm
Phenacetin O-deethylation (CYP1A2)2025010002-Acetamido-phenolHPLC; B87:13 50 mM KH2PO4:CH3CN1.5UV 254 nm
Bupropion hydroxylation (CYP2B6)20250250TrazodoneHPLC; B79:21 50 mM KH2PO4 (pH 3):CH3CN2.0UV 214 nm
S-mephenytoin 4-hydroxylation (CYP2C19)605001000PhenacetinHPLC; B80:20 50 mM KH2PO4:CH3CN1.5UV 204 nm
Conversion of trazodone to m-CPP (CYP3A)6200500DextrorphanHPLC; B80:20 50 mM KH2PO4:CH3CN1.4UV 249 nm
Triazolam 1-hydroxylation (CYP3A)20200500PhenacetinHPLC; A67.5:22.5:10 50 mM KH2PO4:CH3CN:CH3OH1.3UV 220 nm
Diazepam 3-hydroxylation (CYP3A)205001000U-31485 (Pharmacia & Upjohn)GC; 3% SP-2250 packed 6-ft coiled glass, 2 mm i.d. (Supelco); 275°CArgon:methane (95:5)30 63Ni electron-capture detector at 310°C (Hewlett-Packard)
Bufuralol 1′-hydroxylation (CYP2D6)2012580TrazodoneHPLC; B70:30 50 mM KH2PO4:CH3CN1.4Hydroxybufuralol: fluorescence (excitation 530 nm, emission 580 nm); trazodone: UV 230 nm
Desipramine 2-hydroxylation (CYP2D6)10–20250100TrazodoneHPLC; B67:33 50 mM KH2PO4:CH3CN1.3UV 254 nm
Nortriptyline E-10 hydroxylation (CYP2D6)10–20250200ChlorzoxazoneHPLC; B70:30 50 mM KH2PO4:CH3CN1.4UV 240 nm
  • 2-a  A and B refer to C1815-cm × 3.9-mm NovaPak and C18 30-cm × 3.9-mm μBondapak reversed-phase steel columns (Waters), respectively.

  • GC, gas chromatography; m-CPP,meta-chlorophenylpiperazine.